Organizations Filed Purposes:
ODYLIA UTILIZES A UNIQUE, NON-PROFIT BUSINESS MODEL TO ACCELERATE THE DEVELOPMENT OF GENE THERAPIES FOR PEOPLE WITH INHERITED RETINAL DISEASE, CHANGING THE WAY TREATMENTS ARE BROUGHT FROM THE LAB TO THE CLINIC.
SUPPORTING GENE THERAPIES FOR EACH OF THE FOLLOWING RARE DISEASES SO THEY CAN REACH THE CLINICAL TRIAL PHASE. TOP THREE PROGRAMS: RPGRIP1, USH1C, RDH12
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| Ashley Winslow | CHIEF SCIENC | 40 | $42,057 |
| Luk Vandenbergh | BOARD MEMBER | 0 | $0 |
| Matthew Pletcher | BOARD MEMBER | 0 | $0 |
| Emil Kakkis | BOARD MEMBER | 0 | $0 |
| Scott Dorfman | CEO & BOARD | 0 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202012679349301401_public.xml